{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:15:02Z","timestamp":1792887302253,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To verify the regional distribution, especially off-target binding, of the tracer\n                      <jats:sup>18<\/jats:sup>\n                      F-MK-6240, on tau PET images obtained with a high-resolution dedicated brain PET scanner.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed the\n                      <jats:sup>18<\/jats:sup>\n                      F-MK-6240 PET data from subjects with cognitive decline who were enrolled in the BATON study. All scans were acquired using the same high-resolution brain-dedicated PET system. We calculated the standardized uptake value ratios (SUVRs) by using manually defined restricted cerebellar volumes of interest (VOIs) excluding meningeal spill-in, and we compared these SUVRs with those obtained using the conventional CenTauR cerebellar gray matter reference. We also quantified the off-target uptake in regions including the meninges, retina, and ethmoid sinus. Group comparisons and interaction effects were analyzed by\n                      <jats:italic>t<\/jats:italic>\n                      -tests and an ANOVA, and ROC analyses were performed to assess the diagnostic accuracy of each method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Off-target accumulations were clearly observed in the substantia nigra, globus pallidum, and pineal gland. Higher extra-cerebral cortical uptake was observed in the meninges and centrum semiovale in tau-positive individuals, although these differences did not remain significant after a multiple comparison correction. The SUVRs derived with the use of restricted cerebellar VOIs were significantly higher than those from the CenTauR cerebellar VOIs in both the tau-positive and tau-negative groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). A significant interaction between the diagnostic group and the reference VOI choice was detected (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019). The ROC analysis showed excellent diagnostic performance, with AUCs of 0.930 for CenTauR and 0.984 for the restricted reference VOIs (a nonsignificant difference).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-MK-6240 PET imaging using a high-resolution brain-dedicated PET scanner revealed notable off-target binding and meningeal spill-in, which significantly affect quantification depending on the reference VOI selection. Optimizing reference regions by excluding extracerebral contamination enhances the reliability of tau PET analyses and may be crucial for longitudinal studies and multicenter trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12149-026-02161-9","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:20:23Z","timestamp":1770038423000},"page":"597-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Off-target binding of 18F-MK-6240 tau PET imaging demonstrated by high spatial resolution dedicated brain PET scanner"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-952X","authenticated-orcid":false,"given":"Kazunari","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kojita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2161_CR1","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","volume":"57","author":"ED Hostetler","year":"2016","unstructured":"Hostetler ED, Walji AM, Zeng Z, Miller P, Bennacef I, Salinas C, et al. Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles. J Nucl Med. 2016;57:1599\u2013606. https:\/\/doi.org\/10.2967\/jnumed.115.171678.","journal-title":"J Nucl Med"},{"key":"2161_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2967\/jnumed.122.264371","volume":"64","author":"JP Seibyl","year":"2023","unstructured":"Seibyl JP, DuBois JM, Racine A, Collins J, Guo Q, Wooten D, et al. A visual interpretation algorithm for assessing brain tauopathy with (18)F-MK-6240 PET. J Nucl Med. 2023;64:444\u201351. https:\/\/doi.org\/10.2967\/jnumed.122.264371.","journal-title":"J Nucl Med"},{"key":"2161_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12372","volume":"9","author":"JL Shuping","year":"2023","unstructured":"Shuping JL, Matthews DC, Adamczuk K, Scott D, Rowe CC, Kreisl WC, et al. Development, initial validation, and application of a visual read method for [(18)F]MK-6240 tau PET. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions. 2023;9:e12372. https:\/\/doi.org\/10.1002\/trc2.12372.","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"2161_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102708","volume":"31","author":"R Smith","year":"2021","unstructured":"Smith R, Strandberg O, Leuzy A, Betthauser TJ, Johnson SC, Pereira JB, et al. Sex differences in off-target binding using tau positron emission tomography. Neuroimage Clin. 2021;31:102708. https:\/\/doi.org\/10.1016\/j.nicl.2021.102708.","journal-title":"Neuroimage Clin"},{"key":"2161_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2967\/jnumed.118.209650","volume":"60","author":"TJ Betthauser","year":"2019","unstructured":"Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, et al. In vivo characterization and quantification of neurofibrillary tau PET radioligand (18)F-MK-6240 in humans from Alzheimer disease dementia to young controls. J Nucl Med. 2019;60:93\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.209650.","journal-title":"J Nucl Med"},{"key":"2161_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2967\/jnumed.122.264434","volume":"64","author":"C Tissot","year":"2023","unstructured":"Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, et al. The association of age-related and off-target retention with longitudinal quantification of [(18)F]MK6240 tau PET in target regions. J Nucl Med. 2023;64:452\u20139. https:\/\/doi.org\/10.2967\/jnumed.122.264434.","journal-title":"J Nucl Med"},{"key":"2161_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R, et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7:37. https:\/\/doi.org\/10.1186\/s40478-019-0686-6.","journal-title":"Acta Neuropathol Commun"},{"key":"2161_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, et al. In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240. Alzheimers Res Ther. 2018;10:74. https:\/\/doi.org\/10.1186\/s13195-018-0402-y.","journal-title":"Alzheimers Res Ther"},{"key":"2161_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1177\/0271678X19887781","volume":"40","author":"C Salinas","year":"2020","unstructured":"Salinas C, Lohith TG, Purohit A, Struyk A, Sur C, Bennacef I, et al. Test-retest characteristic of [(18)F]MK-6240 quantitative outcomes in cognitively normal adults and subjects with Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2020;40:2179\u201387. https:\/\/doi.org\/10.1177\/0271678X19887781.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2161_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2967\/jnumed.120.254961","volume":"63","author":"A Gogola","year":"2022","unstructured":"Gogola A, Minhas DS, Villemagne VL, Cohen AD, Mountz JM, Pascoal TA, et al. Direct comparison of the tau PET tracers (18)F-Flortaucipir and (18)F-MK-6240 in human subjects. J Nucl Med. 2022;63:108\u201316. https:\/\/doi.org\/10.2967\/jnumed.120.254961.","journal-title":"J Nucl Med"},{"key":"2161_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0271678X221142139","volume":"43","author":"JF Fu","year":"2023","unstructured":"Fu JF, Lois C, Sanchez J, Becker JA, Rubinstein ZB, Thibault E, et al. Kinetic evaluation and assessment of longitudinal changes in reference region and extracerebral [(18)F]MK-6240 PET uptake. J Cereb Blood Flow Metab. 2023;43:581\u201394. https:\/\/doi.org\/10.1177\/0271678X221142139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2161_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12149-022-01721-z","volume":"36","author":"T Mizuta","year":"2022","unstructured":"Mizuta T, Kobayashi T, Yamakawa Y, Hanaoka K, Watanabe S, Morimoto-Ishikawa D, et al. Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET. Ann Nucl Med. 2022;36:420\u20136. https:\/\/doi.org\/10.1007\/s12149-022-01721-z.","journal-title":"Ann Nucl Med"},{"key":"2161_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2967\/jnumed.122.264080","volume":"64","author":"K Ishii","year":"2023","unstructured":"Ishii K, Hanaoka K, Watanabe S, Morimoto-Ishikawa D, Yamada T, Kaida H, et al. High-resolution silicon photomultiplier time-of-flight dedicated head PET system for clinical brain studies. J Nucl Med. 2023;64:153\u20138. https:\/\/doi.org\/10.2967\/jnumed.122.264080.","journal-title":"J Nucl Med"},{"key":"2161_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s12149-022-01788-8","volume":"36","author":"T Mizuta","year":"2022","unstructured":"Mizuta T, Yamakawa Y, Minagawa S, Kobayashi T, Ohtani A, Takenouchi S, et al. Attenuation correction for phantom tests: an alternative to maximum-likelihood attenuation correction factor-based correction for clinical studies in time-of-flight PET. Ann Nucl Med. 2022;36:998\u20131006. https:\/\/doi.org\/10.1007\/s12149-022-01788-8.","journal-title":"Ann Nucl Med"},{"key":"2161_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-022-00518-3","volume":"9","author":"D Morimoto-Ishikawa","year":"2022","unstructured":"Morimoto-Ishikawa D, Hanaoka K, Watanabe S, Yamada T, Yamakawa Y, Minagawa S, et al. Evaluation of the performance of a high-resolution time-of-flight PET system dedicated to the head and breast according to NEMA NU 2-2012 standard. EJNMMI Phys. 2022;9:88. https:\/\/doi.org\/10.1186\/s40658-022-00518-3.","journal-title":"EJNMMI Phys"},{"key":"2161_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10278-023-00902-0","volume":"37","author":"T Kobayashi","year":"2024","unstructured":"Kobayashi T, Shigeki Y, Yamakawa Y, Tsutsumida Y, Mizuta T, Hanaoka K, et al. Generating PET attenuation maps via sim2real deep learning-based tissue composition estimation combined with MLACF. J Imaging Inform Med. 2024;37:167\u201379. https:\/\/doi.org\/10.1007\/s10278-023-00902-0.","journal-title":"J Imaging Inform Med"},{"key":"2161_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12149-024-01986-6","volume":"39","author":"T Yamada","year":"2025","unstructured":"Yamada T, Hanaoka K, Morimoto-Ishikawa D, Yamakawa Y, Kumakawa S, Ohtani A, et al. Crossover evaluation of time-of-flight-based attenuation correction in brain (18)F-FDG and (18)F-flutemetamol PET. Ann Nucl Med. 2025;39:189\u201398. https:\/\/doi.org\/10.1007\/s12149-024-01986-6.","journal-title":"Ann Nucl Med"},{"key":"2161_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95\u2013113. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.07.007.","journal-title":"Neuroimage"},{"key":"2161_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12454","volume":"15","author":"VL Villemagne","year":"2023","unstructured":"Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, et al. CenTauR: toward a universal scale and masks for standardizing tau imaging studies. Alzheimers Dement Amst. 2023;15:e12454. https:\/\/doi.org\/10.1002\/dad2.12454.","journal-title":"Alzheimers Dement Amst"},{"key":"2161_CR20","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1002\/alz.13908","volume":"20","author":"A Leuzy","year":"2024","unstructured":"Leuzy A, Raket LL, Villemagne VL, Klein G, Tonietto M, Olafson E, et al. Harmonizing tau positron emission tomography in Alzheimer\u2019s disease: the CenTauR scale and the joint propagation model. Alzheimers Dement. 2024;20:5833\u201348. https:\/\/doi.org\/10.1002\/alz.13908.","journal-title":"Alzheimers Dement"},{"key":"2161_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12149-022-01808-7","volume":"37","author":"A Ohnishi","year":"2023","unstructured":"Ohnishi A, Akamatsu G, Ikari Y, Nishida H, Shimizu K, Matsumoto K, et al. Dosimetry and efficacy of a tau PET tracer [(18)F]MK-6240 in Japanese healthy elderly and patients with Alzheimer\u2019s disease. Ann Nucl Med. 2023;37:108\u201320. https:\/\/doi.org\/10.1007\/s12149-022-01808-7.","journal-title":"Ann Nucl Med"},{"key":"2161_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.25060","volume":"82","author":"DR Schonhaut","year":"2017","unstructured":"Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr., et al. (18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol. 2017;82:622\u201334. https:\/\/doi.org\/10.1002\/ana.25060.","journal-title":"Ann Neurol"},{"key":"2161_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab190","volume":"3","author":"T Tezuka","year":"2021","unstructured":"Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, et al. Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. Brain Commun. 2021;3:fcab190. https:\/\/doi.org\/10.1093\/braincomms\/fcab190.","journal-title":"Brain Commun"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02161-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:50:29Z","timestamp":1781632229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02161-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict\u00a0interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Certified Review Boad of National Institutes for Quantum Science and Technology (Date: July. 30, 2021\/CRB3180004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}